Journal
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 25, Issue 4, Pages 543-559Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.beem.2011.05.010
Keywords
coactivator; corepressor; 1 alpha,25-dihydroxyvitamin D-3; ligand conformation; genomic responses; rapid responses; retinoid X receptor; transcription; vitamin D receptor; vitamin D responsive elements
Categories
Ask authors/readers for more resources
The conformationally flexible secosteroid, 1 alpha,25(OH)(2)vitamin D-3 (1 alpha,25(OH)(2)D-3) initiates biological responses via binding to the vitamin D receptor (VDR). The VDR contains two overlapping ligand binding sites, a genomic pocket (VDR-GP) and an alternative pocket (VDR-AP), that respectively bind a bowl-like ligand configuration (gene transcription) or a planar-like ligand shape (rapid responses). When occupied by 1 alpha,25(OH)(2)D-3, the VDR-GP interacts with the retinoid X receptor to form a heterodimer that binds to vitamin D responsive elements in the region of genes directly controlled by 1 alpha,25(OH)(2)D-3. By recruiting complexes of either coactivators or corepressors, activated VDR modulates the transcription of genes encoding proteins that promulgate the traditional genomic functions of vitamin D, including signaling intestinal calcium and phosphate absorption to effect skeletal and calcium homeostasis. 1 alpha,25(OH)(2)D-3/VDR control of gene expression and rapid responses also delays chronic diseases of aging such as osteoporosis, cancer, type-1 and -2 diabetes, arteriosclerosis, vascular disease, and infection. (C) 2011 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available